Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:19:30 EDT Sun 13 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:PSNL - PERSONALIS INC - https://www.personalis.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PSNL - Q0.116.20·18.001.016.21-0.12-0.71,407.022,3169,72316.46  16.58  16.1918.89  4.95519:30:06Aug 0415 min RT 2¢

Recent Trades - Last 10 of 9723
Time ETExPriceChangeVolume
19:30:06Q16.21-0.121
19:30:06Q16.21-0.121
19:30:04Q16.21-0.121
19:30:04Q16.21-0.121
18:04:58Q16.20-0.1330
17:06:51Q16.20-0.1312
16:29:27Q16.21-0.1274
16:29:27Q16.2003-0.129774
16:15:00Q16.21-0.121
16:15:00Q16.21-0.121

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-08-04 16:01U:PSNLNews ReleasePersonalis Reports Second Quarter Results and Recent Highlights
2026-07-20 08:35U:PSNLNews ReleaseTempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
2026-07-14 06:00U:PSNLNews ReleasePersonalis Accelerates Global Expansion with UKCA Marking for NeXT Personal(TM), Expanding MRD Access and Biopharma Support in Great Britain
2026-06-09 06:00U:PSNLNews ReleasePersonalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
2026-06-02 06:00U:PSNLNews ReleasePersonalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
2026-05-26 06:00U:PSNLNews ReleasePersonalis to Highlight Breadth of NeXT Personal(TM) Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
2026-05-20 06:00U:PSNLNews ReleasePersonalis Secures Fourth Medicare Coverage Decision for NeXT Personal(TM), Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
2026-05-14 16:01U:PSNLNews ReleasePersonalis to Participate in Upcoming Investor Events
2026-05-13 06:00U:PSNLNews ReleasePersonalis Receives Medicare Coverage for NeXT Personal(TM) for Immunotherapy Monitoring Across Late-stage Solid Tumors
2026-05-07 16:01U:PSNLNews ReleasePersonalis Reports First Quarter Results and Recent Highlights
2026-04-23 16:01U:PSNLNews ReleasePersonalis to Announce First Quarter 2026 Financial Results
2026-04-21 06:00U:PSNLNews ReleasePersonalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
2026-04-13 06:00U:PSNLNews ReleasePersonalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
2026-04-01 16:01U:PSNLNews ReleasePersonalis to Participate in the 25th Annual Needham Virtual Conference
2026-03-17 16:00U:PSNLNews ReleasePersonalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption
2026-03-12 06:00U:PSNLNews ReleasePersonalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal(TM)
2026-02-26 16:01U:PSNLNews ReleasePersonalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
2026-02-17 16:01U:PSNLNews ReleasePersonalis to Participate in the TD Cowen 46th Annual Healthcare Conference
2026-02-12 16:01U:PSNLNews ReleasePersonalis to Announce Fourth Quarter and Full Year 2025 Financial Results